 |
 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
E-Mail
ShareIntegrase Inhibitors
Integrase Inhibitors in Development
- Elvitegravir "Quad" Pill Performs Well, New Booster Cobicistat Works as Well as Ritonavir (February 18, 2010)
From aidsmap.com - The New Quad on the Block: Gilead's Four-Drug, Fixed-Dose Combination With a Novel Booster Sails Through Phase 2 Trials (Feb. 18, 2010; 1:15 a.m. Pacific Time)
A blog entry from CROI 2010 by Myles Helfand.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Key Retrovirus Enzyme Grown in Lab (February 1, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation - Peering in the Pipeline (Summer 2009)
To read PDF, click here.
In Achieve, from ACRIA and GMHC - Shionogi-GlaxoSmithKline Pharmaceuticals Acknowledges Position of the European AIDS Treatment Group and the AIDS Treatment Activists Coalition to Revise Protocol for ING112276, a Clinical Study for S/GSK1349572 (August 13, 2009)
From GlaxoSmithKline - Could Isentress (or Other Integrase Inhibitors) Be Used as an HIV Prevention Drug? (April 28, 2009)
From aidsmap.com - Gilead Initiates Phase II Clinical Trial of Integrase-Based, Single-Tablet, Once-Daily Regimen for the Treatment of HIV (April 17, 2009)
Study will assess safety and efficacy of single-tablet regimen containing elvitegravir boosted by GS 9350 and Truvada compared to Atripla.
From Gilead Sciences, Inc. - Comparing Two Integrase Inhibitors (September/October 2008)
A guide geared for patients.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network - HIV-1 Integrase Inhibitors (June 23, 2008)
An overview on a new HIV medication class.
In The PRN Notebook - Cross-Resistance Between Integrase Inhibitors Looks Likely (June 12-16, 2007)
From National AIDS Treatment Advocacy Project - Another Integrase Inhibitor -- Elvitegravir (GS-9137) -- Progresses in Development (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Understanding and Inhibiting Integrase in the Treatment of HIV Disease (November 2006)
In The PRN Notebook - Integrase Inhibitors: The Next Wave? (Spring 2006)
A quick look at MK-518 and GS-9137.
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - Integrase Inhibitors in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body